| Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients (NCT00393120) | Incyte Corporation | 2006-10-01 |
| Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults (NCT00389207) | Boehringer Ingelheim | 2006-10-01 |
| Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children (NCT00339040) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| HIV and STD Prevention for High-Risk, Inner-City, African American Youth (NCT00353405) | University of Pennsylvania | 2006-10-01 |
| STD Risk Reduction for Heterosexual Methamphetamine Users (NCT00344214) | University of California, San Diego | 2006-10-01 |
| Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED) (NCT00350623) | Merck Sharp & Dohme LLC | 2006-10-01 |
| A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART) (NCT00532974) | Epimmune | 2006-10-01 |
| Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection (NCT00386633) | Bavarian Nordic | 2006-10-01 |
| Safety Study Of Nasal HIV Vaccine Adjuvanted With LTK63 (NCT00369031) | St George's, University of London | 2006-09-01 |
| All About Youth: Evaluation of Sexual Risk Avoidance and Risk Reduction Programs for Middle School Students (NCT00167505) | The University of Texas Health Science Center, Houston | 2006-09-01 |
| Testing an HIV Prevention Intervention for Psychiatric Patients in Brazil (NCT00881699) | New York State Psychiatric Institute | 2006-09-01 |
| Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) (NCT00381017) | Merck Sharp & Dohme LLC | 2006-09-01 |
| TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously (NCT00513513) | Tibotec Pharmaceuticals, Ireland | 2006-09-01 |
| Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy (NCT00307164) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-01 |
| Lopinavir Capsules to Kaletra or Invirase Tablets (NCT00438152) | Royal Free Hampstead NHS Trust | 2006-09-01 |
| Safety Study of Elvucitabine in HIV-1 Subjects (NCT00405249) | Thomas Jefferson University | 2006-09-01 |
| Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone (NCT00362726) | Bristol-Myers Squibb | 2006-09-01 |
| Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2) (NCT00371592) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-09-01 |
| The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215 (NCT01034800) | National Institute on Drug Abuse (NIDA) | 2006-09-01 |
| FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment (NCT00414635) | Community Research Initiative of New England | 2006-08-01 |
| Efficacy of Group Intervention to Reduce Stress Symptoms (NCT00611338) | Stanford University | 2006-08-01 |
| SHARE: Simple HAART With Abacavir, Reyataz, and Epivir (NCT00426296) | Clinical Alliance for Research & Education - Infectious Diseases, LLC. | 2006-08-01 |
| Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients. (NCT00531206) | Boehringer Ingelheim | 2006-08-01 |
| Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya (NCT00838292) | Academy for Educational Development | 2006-08-01 |
| Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV (NCT02229760) | Boehringer Ingelheim | 2006-08-01 |
| Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients (NCT00517569) | Genexine, Inc. | 2006-08-01 |
| A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT) (NCT00369941) | Merck Sharp & Dohme LLC | 2006-08-01 |
| Valganciclovir to Reduce T Cell Activation in HIV Infection (NCT00264290) | University of California, San Francisco | 2006-08-01 |
| Rosiglitazone Effect on Mitochondria and Lipoatrophy (NCT00367744) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-07-01 |
| Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence (NCT00548275) | Yale University | 2006-07-01 |
| BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes (NCT00389402) | International Antiviral Therapy Evaluation Center | 2006-07-01 |
| C2P - Phase III: MPowerment and Community Promise (NCT00381784) | University of North Carolina, Chapel Hill | 2006-07-01 |
| VENICE Study Nevirapine Full Dose/Dose Escalation (NCT00704249) | Clinical Trial Agency of HIV Study Group | 2006-07-01 |
| Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients (NCT00358696) | University of British Columbia | 2006-07-01 |
| A Mindfulness Based Approach to HIV Treatment Side Effects (NCT00312936) | University of California, San Francisco | 2006-07-01 |
| Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects (NCT00357188) | Bristol-Myers Squibb | 2006-07-01 |
| Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities (NCT00255840) | CIPRA SA | 2006-07-01 |
| Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females (NCT00357604) | Bristol-Myers Squibb | 2006-07-01 |
| Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients (NCT00390780) | Valerio Therapeutics | 2006-07-01 |
| Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers (NCT00648817) | Gilead Sciences | 2006-07-01 |
| Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients (NCT00365612) | Gilead Sciences | 2006-07-01 |
| Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects (NCT00352911) | VGX Pharmaceuticals, LLC | 2006-07-01 |
| Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy (NCT00352053) | Gilead Sciences | 2006-06-01 |
| Nutrition Intervention in Drug Naive HIV-infected Kenyan Women and Their Children (NCT00562874) | Indiana University | 2006-06-01 |
| Acute HIV Infection Observational Study (NCT00296660) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection (NCT00337701) | Hoffmann-La Roche | 2006-06-01 |
| Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment (NCT00379405) | Germans Trias i Pujol Hospital | 2006-06-01 |
| Lopinavir/Ritonavir (Kaletra) PK in Children (NCT00810108) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2006-06-01 |
| Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy (NCT00959361) | Hospital de Clinicas de Porto Alegre | 2006-06-01 |
| A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects (NCT00334659) | Avexa | 2006-06-01 |
| Life Skills Intervention for Adolescents Perinatally Infected With HIV (NCT00272519) | University of North Carolina, Chapel Hill | 2006-06-01 |
| A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents (NCT00355524) | Tibotec Pharmaceuticals, Ireland | 2006-06-01 |
| Study of Valproic Acid to Treat HIV Infected Adults (NCT00312546) | University of North Carolina, Chapel Hill | 2006-06-01 |
| Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (NCT00321672) | NeurogesX | 2006-06-01 |
| BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) (NCT00414284) | Community Research Initiative of New England | 2006-06-01 |
| Valproic Acid and Its Effects on HIV Latent Reservoirs (NCT00289952) | Jean-Pierre Routy | 2006-06-01 |
| Drug Interaction Study With Proton Pump Inhibitor (NCT00357240) | Bristol-Myers Squibb | 2006-06-01 |
| Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm (NCT00076817) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| China Antiretroviral Treatment Adherence for Life (NCT00661258) | Boston University | 2006-06-01 |
| Subclinical Atherosclerosis in HIV-infected Patients (NCT00455793) | Massachusetts General Hospital | 2006-06-01 |
| Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients (NCT00316589) | Bavarian Nordic | 2006-06-01 |
| Exercise, Oxidative Stress and HIV (NCT00950937) | Hospital de Clinicas de Porto Alegre | 2006-06-01 |
| Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women (NCT00100867) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2006-06-01 |
| Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT) (NCT00346567) | Rigshospitalet, Denmark | 2006-06-01 |
| Atazanavir Twice Daily (NCT00357721) | Bristol-Myers Squibb | 2006-06-01 |
| Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth (NCT00109590) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor (NCT00432783) | Montefiore Medical Center | 2006-06-01 |
| Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV (NCT00270296) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis (NCT00385645) | Hospital Clinic of Barcelona | 2006-05-01 |
| Highly Active Antiretroviral Therapy (HAART) Adherence Interventions (NCT00273780) | University of Washington | 2006-05-01 |
| Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People (NCT00078442) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Effects of HIV and Hepatitis C Virus on the Brain (NCT00494936) | Icahn School of Medicine at Mount Sinai | 2006-05-01 |
| Metabolic Effects of Switching Kaletra to Boosted Reyataz (NCT00413153) | Massachusetts General Hospital | 2006-05-01 |
| Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants (NCT00350272) | Alexion Pharmaceuticals, Inc. | 2006-05-01 |
| ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency (NCT00493506) | Health Enhancement Products, Inc. | 2006-05-01 |
| Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults (NCT00123968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women (NCT00362375) | Centers for Disease Control and Prevention | 2006-05-01 |
| The Effect of Bacille Calmette Guerin (BCG) Vaccination on Immune Responses in HIV-Exposed and Unexposed Infants (NCT00331474) | University of Stellenbosch | 2006-05-01 |
| Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir (NCT00486330) | Yale University | 2006-05-01 |
| DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) (NCT00302341) | Immtech Pharmaceuticals, Inc | 2006-05-01 |
| Phase I Study of Vaccination Schedule of Experimental HIV Vaccines (NCT00321061) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-25 |
| Alveolar Macrophage Proteomics in HIV-associated Emphysema (NCT00823927) | Philip Diaz | 2006-04-21 |
| PREventing Progression of Adipose Tissue Redistribution (NCT00389194) | International Antiviral Therapy Evaluation Center | 2006-04-01 |
| Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV (NCT00545558) | University of Cincinnati | 2006-04-01 |
| Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir (NCT00365339) | Bristol-Myers Squibb | 2006-04-01 |
| Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks* (NCT00511368) | Myrexis Inc. | 2006-04-01 |
| Reducing HIV Risks in African American Teens (NCT00963963) | Education Development Center, Inc. | 2006-04-01 |
| Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults (NCT00301184) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Directly Observed Therapy for HIV Infected Adolescents (NCT00259389) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs (NCT00300573) | Incyte Corporation | 2006-04-01 |
| When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study) (NCT00234091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Directly Administered HIV Therapy in Methadone Clinics (NCT00279110) | Johns Hopkins University | 2006-04-01 |
| Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis (NCT00698334) | All India Institute of Medical Sciences | 2006-04-01 |
| Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA) (NCT00312169) | Orlando Immunology Center | 2006-04-01 |
| Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130) (NCT00302822) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-04-01 |
| Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications (NCT00433992) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa (NCT00346476) | CIPRA SA | 2006-04-01 |
| Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation (NCT00312039) | Alexion Pharmaceuticals, Inc. | 2006-03-31 |
| BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. (NCT00326963) | Hoffmann-La Roche | 2006-03-01 |
| SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients (NCT00299897) | Samaritan Pharmaceuticals, Inc | 2006-03-01 |